327 related articles for article (PubMed ID: 6099068)
1. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Wilkinson DS
Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural studies of necrolytic migratory erythema.
Ohyama K; Kitoh M; Arao T
Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
[TBL] [Abstract][Full Text] [Related]
3. [Glucagonoma syndrome. Unusual histologic image].
Poiares Baptista A; Tellechea O; Aguiar M; Leitão A
Ann Dermatol Venereol; 1987; 114(1):55-8. PubMed ID: 3034125
[No Abstract] [Full Text] [Related]
4. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
5. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
Pedersen NB; Jonsson L; Holst JJ
Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
[TBL] [Abstract][Full Text] [Related]
6. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
Technau K; Renkl A; Norgauer J; Ziemer M
Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
[TBL] [Abstract][Full Text] [Related]
7. [The glucagonoma syndrome].
Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
[TBL] [Abstract][Full Text] [Related]
8. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
Chaw L; Krop TM; Hood AF
Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
[No Abstract] [Full Text] [Related]
9. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
Gantcheva ML; Broshtilova VK; Lalova AI
Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
[No Abstract] [Full Text] [Related]
10. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
Kitoh M; Ohyama K; Shigeo ; Arao AT
Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
[No Abstract] [Full Text] [Related]
11. A patient with long-standing skin lesions. Necrolytic migratory erythema.
Netea RT; Erceg A; Pieters G; Hermus AR
Neth J Med; 2004 Dec; 62(11):453, 462. PubMed ID: 15685896
[No Abstract] [Full Text] [Related]
12. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
Skouge JW; Farmer ER
Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
[No Abstract] [Full Text] [Related]
13. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
Smith AP; Doolas A; Staren ED
J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
[TBL] [Abstract][Full Text] [Related]
14. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
Kasper CS
Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
[TBL] [Abstract][Full Text] [Related]
15. [Glucagonoma syndrome].
Picard C; Mazer JM; Bilet S; Villette B; Penchet A; Toublanc M; Grossin M; Debussche X; Assan R; Belaïch S
Ann Dermatol Venereol; 1988; 115(11):1142-5. PubMed ID: 2853600
[No Abstract] [Full Text] [Related]
16. [Glucagonoma syndrome].
Coindre MC; Fétissoff F; Lemaire M; Garrigue MA; Lorette G
Ann Dermatol Venereol; 1985; 112(11):911-4. PubMed ID: 3004309
[No Abstract] [Full Text] [Related]
17. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
Elsborg L; Glenthøj A
Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
[TBL] [Abstract][Full Text] [Related]
18. Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: is hepatic impairment a clue to pathogenesis?
Kasper CS; McMurry K
J Am Acad Dermatol; 1991 Sep; 25(3):534-41. PubMed ID: 1655838
[TBL] [Abstract][Full Text] [Related]
19. [Necrolytic migratory erythema. A marker of systemic disease].
de Cristancho NP; Rivera J; de Arriaga AD
Rev Clin Esp; 1994 Aug; 194(8):654. PubMed ID: 7938851
[No Abstract] [Full Text] [Related]
20. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
Vandersteen PR; Scheithauer BW
J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
